Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
INDUSTRY
×
melflufen
×
Clear all
Filters
3
NCT03151811
2024-01-30
OCEAN
Oncopeptides AB
Phase 3
Terminated
495 enrolled
15 charts
NCT04649060
2023-06-08
LIGHTHOUSE
Oncopeptides AB
Phase 3
Terminated
54 enrolled
21 charts